-
1
-
-
0029639032
-
Ovarian cancer: Screening, treatment and follow-up NIH consensus development panel on ovarian cancer
-
NIH Consensus Conference
-
NIH Consensus Conference. Ovarian cancer: screening, treatment and follow-up NIH consensus development panel on ovarian cancer. JAMA, 273: 491-497, 1995.
-
(1995)
JAMA
, vol.273
, pp. 491-497
-
-
-
2
-
-
0027382941
-
Cancer of the ovary
-
Cannistra, S. A. Cancer of the ovary. N. Engl. J Med., 329: 1550-1559, 1993
-
(1993)
N. Engl. J Med.
, vol.329
, pp. 1550-1559
-
-
Cannistra, S.A.1
-
3
-
-
0029038204
-
Treatment of advanced epithelial ovarian cancer: Past, present and future
-
Hoskins, P. J. Treatment of advanced epithelial ovarian cancer: past, present and future. Crit. Rev. Oncol. Hematol., 20: 41-59, 1995.
-
(1995)
Crit. Rev. Oncol. Hematol.
, vol.20
, pp. 41-59
-
-
Hoskins, P.J.1
-
4
-
-
0028965016
-
The treatment of epithelial ovarian cancer
-
Qazi, F., and McGuire W. P. The treatment of epithelial ovarian cancer. CA Cancer J. Clin., 45: 88-101, 1995.
-
(1995)
CA Cancer J. Clin.
, vol.45
, pp. 88-101
-
-
Qazi, F.1
McGuire, W.P.2
-
5
-
-
0028078681
-
Dose-intense taxol: High response rate in patients with platinum-resistant recurrent ovarian cancer
-
Kohn, E. C., Sarosy, G., Bicher, A., Link, C., Christian, M., Steinberg, S. M., Rothenberg, M., Adamo, D. O., Davis, P., Ognibene, F. P., Cunnion, R. E., and Reed, E. Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer. J. Natl. Cancer Inst., 86: 18-24, 1994.
-
(1994)
J. Natl. Cancer Inst.
, vol.86
, pp. 18-24
-
-
Kohn, E.C.1
Sarosy, G.2
Bicher, A.3
Link, C.4
Christian, M.5
Steinberg, S.M.6
Rothenberg, M.7
Adamo, D.O.8
Davis, P.9
Ognibene, F.P.10
Cunnion, R.E.11
Reed, E.12
-
6
-
-
0026504147
-
Social controls on cell survival and cell death
-
Raff, M. C. Social controls on cell survival and cell death. Nature (Lond.), 356: 397-400, 1992.
-
(1992)
Nature (Lond.)
, vol.356
, pp. 397-400
-
-
Raff, M.C.1
-
7
-
-
0028268215
-
Programmed cell death and bcl-2 protection in the absence of a nucleus
-
Jacobson, M. D., Burne, J. F., and Raff, M. C. Programmed cell death and bcl-2 protection in the absence of a nucleus. EMBO J., 13: 1899-1910, 1994.
-
(1994)
EMBO J.
, vol.13
, pp. 1899-1910
-
-
Jacobson, M.D.1
Burne, J.F.2
Raff, M.C.3
-
8
-
-
0019225636
-
Cell death: The significance of apoptosis
-
Wyllie, A. H., Kerr, J. F. R., and Currie, A. R. Cell death: the significance of apoptosis. Int. Rev. Cytol., 68: 251-301, 1980.
-
(1980)
Int. Rev. Cytol.
, vol.68
, pp. 251-301
-
-
Wyllie, A.H.1
Kerr, J.F.R.2
Currie, A.R.3
-
9
-
-
0025932984
-
Apoptosis: Mechanisms and roles in pathology
-
Arends, M. J., and Wyllie, A. H. Apoptosis: mechanisms and roles in pathology. Int. Rev. Exp Pathol., 32: 223-254, 1991.
-
(1991)
Int. Rev. Exp Pathol.
, vol.32
, pp. 223-254
-
-
Arends, M.J.1
Wyllie, A.H.2
-
10
-
-
0028943734
-
Apoptosis in the pathogenesis and treatment of disease
-
Washington DC
-
Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 264: 1456-1462, 1995.
-
(1995)
Science
, vol.264
, pp. 1456-1462
-
-
Thompson, C.B.1
-
11
-
-
0018830636
-
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
-
Wyllie, A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (Lond.), 284: 555-556, 1980.
-
(1980)
Nature (Lond.)
, vol.284
, pp. 555-556
-
-
Wyllie, A.H.1
-
12
-
-
0026720052
-
The topoisomerase II inhibitor teniposide (VM-26) induces apoptosis in unstimulated mature murine lymphocytes
-
Roy, C. Brown, D. L., Little, J. E., Valentine, B. K., Walker, P. R., Sikorska, M., Leblanc, J., and Chaly, N. The topoisomerase II inhibitor teniposide (VM-26) induces apoptosis in unstimulated mature murine lymphocytes. Exp. Cell Res , 200: 416-424, 1992.
-
(1992)
Exp. Cell Res
, vol.200
, pp. 416-424
-
-
Roy, C.1
Brown, D.L.2
Little, J.E.3
Valentine, B.K.4
Walker, P.R.5
Sikorska, M.6
Leblanc, J.7
Chaly, N.8
-
13
-
-
0026680874
-
Apoptosis and programmed cell death in immunity
-
Cohen, J. J., Duke, R. C., Fadok, V. A., and Sellins, K. S. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol., 10: 267-293, 1992.
-
(1992)
Annu. Rev. Immunol.
, vol.10
, pp. 267-293
-
-
Cohen, J.J.1
Duke, R.C.2
Fadok, V.A.3
Sellins, K.S.4
-
14
-
-
0028263376
-
Cis-DDP induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA
-
Ormerod, M. G., O'Neill, C. F., Robertson, D., and Harrap, K. R. Cis-DDP induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. Exp. Cell Res., 211: 231-237, 1994.
-
(1994)
Exp. Cell Res.
, vol.211
, pp. 231-237
-
-
Ormerod, M.G.1
O'Neill, C.F.2
Robertson, D.3
Harrap, K.R.4
-
15
-
-
0027217084
-
Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation
-
Oberhammer, F., Wilson, J. W., Dive, C., Morris, I. D., Hickman, J. A., Wakeling, A. E., Walker, P. R., and Sikorska, M. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J., 12: 3679-3684, 1993.
-
(1993)
EMBO J.
, vol.12
, pp. 3679-3684
-
-
Oberhammer, F.1
Wilson, J.W.2
Dive, C.3
Morris, I.D.4
Hickman, J.A.5
Wakeling, A.E.6
Walker, P.R.7
Sikorska, M.8
-
16
-
-
0026788002
-
Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation
-
Cohen, G. M., Sun, X. M., Snowden, R. T., Dinsdale, D.. and Skilleter, D. N. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J., 286: 331-334, 1992.
-
(1992)
Biochem. J.
, vol.286
, pp. 331-334
-
-
Cohen, G.M.1
Sun, X.M.2
Snowden, R.T.3
Dinsdale, D.4
Skilleter, D.N.5
-
17
-
-
0025129214
-
The role of peptide growth factors in epithelial ovarian cancer
-
Berchuck, A., Olt, G. J., Everitt, L., Soisson, A., Bast, R., and Boyer, C. M. The role of peptide growth factors in epithelial ovarian cancer. Obstet. Gynecol., 75: 255-262, 1990.
-
(1990)
Obstet. Gynecol.
, vol.75
, pp. 255-262
-
-
Berchuck, A.1
Olt, G.J.2
Everitt, L.3
Soisson, A.4
Bast, R.5
Boyer, C.M.6
-
18
-
-
0002262758
-
Role of growth factors: Their receptors and signalling pathways in the diagnosis, prognosis, follow-up and therapy of ovarian cancer
-
Mills, G., Hashimoto, S., Hurteau, J., Campbell, S., Rubin, L., and Shaw, P. Role of growth factors: their receptors and signalling pathways in the diagnosis, prognosis, follow-up and therapy of ovarian cancer. Diagn. Oncol., 2: 39-54, 1992.
-
(1992)
Diagn. Oncol.
, vol.2
, pp. 39-54
-
-
Mills, G.1
Hashimoto, S.2
Hurteau, J.3
Campbell, S.4
Rubin, L.5
Shaw, P.6
-
19
-
-
0025047803
-
Activation of programmed cell death (apoptosis) by cis-DDP, other anti-cancer drugs, toxins, and hyperthermia
-
Barry, M. A., Behnke, C. A., and Eastman, A. Activation of programmed cell death (apoptosis) by cis-DDP, other anti-cancer drugs, toxins, and hyperthermia. Biochem. Pharmacol., 40: 2353-2362, 1990.
-
(1990)
Biochem. Pharmacol.
, vol.40
, pp. 2353-2362
-
-
Barry, M.A.1
Behnke, C.A.2
Eastman, A.3
-
20
-
-
0025273308
-
Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cis-DDP
-
Sorensen, C. M., Barry, M. A., and Eastman, A. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cis-DDP. J. Natl. Cancer Inst., 82: 749-755, 1990.
-
(1990)
J. Natl. Cancer Inst.
, vol.82
, pp. 749-755
-
-
Sorensen, C.M.1
Barry, M.A.2
Eastman, A.3
-
21
-
-
0028144364
-
The role of apoptosis in cell killing by cis-DDP: A flow-cytometric study
-
Ormerod, M. G., Orr, R. M., and Peacock, J. H. The role of apoptosis in cell killing by cis-DDP: a flow-cytometric study. Br. J. Cancer, 69: 93-100, 1994.
-
(1994)
Br. J. Cancer
, vol.69
, pp. 93-100
-
-
Ormerod, M.G.1
Orr, R.M.2
Peacock, J.H.3
-
22
-
-
0027222563
-
Effects of cis-DDP on the induction of apoptosis in proliferating hepatoma cells and non-proliferating immature thymocytes
-
Evans, D. L., and Dive, C. Effects of cis-DDP on the induction of apoptosis in proliferating hepatoma cells and non-proliferating immature thymocytes. Cancer Res., 53: 2133-2139, 1993.
-
(1993)
Cancer Res.
, vol.53
, pp. 2133-2139
-
-
Evans, D.L.1
Dive, C.2
-
23
-
-
0028239066
-
Cell death and DNA fragmentation induced by liposomal platinum (II) complex L-NDDP in A2780 and A2780/PDD cells
-
Han, I., Ling, Y. H., Khokhar, A., and Perez-Soler, R. Cell death and DNA fragmentation induced by liposomal platinum (II) complex L-NDDP in A2780 and A2780/PDD cells. Anticancer Res., 14: 421-426, 1994.
-
(1994)
Anticancer Res.
, vol.14
, pp. 421-426
-
-
Han, I.1
Ling, Y.H.2
Khokhar, A.3
Perez-Soler, R.4
-
24
-
-
0028925744
-
Rapamycin enhances apoptosis and increases sensitivity to Cis-DDP in vitro
-
Shi, Y., Frankel, A., Radvanyi, L. G., Penn, L. Z., Miller, R. G., and Mills, G. Rapamycin enhances apoptosis and increases sensitivity to Cis-DDP in vitro. Cancer Res., 55: 1982-1988, 1995
-
(1995)
Cancer Res.
, vol.55
, pp. 1982-1988
-
-
Shi, Y.1
Frankel, A.2
Radvanyi, L.G.3
Penn, L.Z.4
Miller, R.G.5
Mills, G.6
-
25
-
-
0026698173
-
Apoptosis induced by anti-cancer drugs
-
Hickman, J. A. Apoptosis induced by anti-cancer drugs. Cancer Metastasis Rev., 11: 121-139, 1992.
-
(1992)
Cancer Metastasis Rev.
, vol.11
, pp. 121-139
-
-
Hickman, J.A.1
-
26
-
-
0025880971
-
A Drug-target interactions only the first step in the commitment to a programmed cell death?
-
Dive, C., and Hickman, J. A Drug-target interactions only the first step in the commitment to a programmed cell death? Br. J. Cancer, 64: 192-196, 1991.
-
(1991)
Br. J. Cancer
, vol.64
, pp. 192-196
-
-
Dive, C.1
Hickman, J.2
-
27
-
-
0029047715
-
Chemotherapy-induced apoptosis in epithelial ovarian cancers
-
Havrilesky, L. J., Elbendary, A., Hurteau, J., Whitaker, R., Rodriguez, G., and Berchuck, A. Chemotherapy-induced apoptosis in epithelial ovarian cancers. Obstet. Gynecol., 85: 1007-1010, 1995.
-
(1995)
Obstet. Gynecol.
, vol.85
, pp. 1007-1010
-
-
Havrilesky, L.J.1
Elbendary, A.2
Hurteau, J.3
Whitaker, R.4
Rodriguez, G.5
Berchuck, A.6
-
28
-
-
0023139408
-
Analysis of human ascites effect on clonogenic growth of human tumor cell lines and NRK-49F cells in soft agar
-
Broxterman, H. J., Sprenkels-Schotte, C., Englen. P., Leyva, A., and Pinedo, H. Analysis of human ascites effect on clonogenic growth of human tumor cell lines and NRK-49F cells in soft agar. Int. J. Cell Cloning, 5: 158-169, 1987.
-
(1987)
Int. J. Cell Cloning
, vol.5
, pp. 158-169
-
-
Broxterman, H.J.1
Sprenkels-Schotte, C.2
Englen, P.3
Leyva, A.4
Pinedo, H.5
-
29
-
-
0023860289
-
A putative new growth factor in ascitic fluid from ovarian cancer patients: Identification, characterization, and mechanism of action
-
Mills, G. B, May, C., McGill, M., Roifman, C. M., and Mellors, A. A. A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action. Cancer Res., 48: 1066-1071, 1988.
-
(1988)
Cancer Res.
, vol.48
, pp. 1066-1071
-
-
Mills, G.B.1
May, C.2
McGill, M.3
Roifman, C.M.4
Mellors, A.A.5
-
30
-
-
0025011698
-
Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells
-
Mills, G. B, May, C., Hill, M., Campbell, S., Shaw, P., and Marks, A. Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells. J Clin. Invest., 86: 851-855, 1990.
-
(1990)
J Clin. Invest.
, vol.86
, pp. 851-855
-
-
Mills, G.B.1
May, C.2
Hill, M.3
Campbell, S.4
Shaw, P.5
Marks, A.6
-
31
-
-
0026071006
-
A comparison of the growth promoting properties of ascitic fluids, cyst fluids and peritoneal fluids from patients with ovarian tumours
-
Wilson, A. P., Fox, H., Scott, I. V., Lee, H., Dent, M., and Golding, P. A comparison of the growth promoting properties of ascitic fluids, cyst fluids and peritoneal fluids from patients with ovarian tumours. Br. J. Cancer, 63: 102-108, 1991.
-
(1991)
Br. J. Cancer
, vol.63
, pp. 102-108
-
-
Wilson, A.P.1
Fox, H.2
Scott, I.V.3
Lee, H.4
Dent, M.5
Golding, P.6
-
32
-
-
0028871499
-
Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients
-
Xu, Y , Gaudette, D., Boynton, J. D., Frankel, A., Fang. X-J., Sharma, A., Hurteau, J., Casey G., Goodbody, A., Mellors, A., Holub, B., and Mills, G. B. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients Clin. Cancer Res., 1: 1223-1232, 1995.
-
(1995)
Clin. Cancer Res.
, vol.1
, pp. 1223-1232
-
-
Xu, Y.1
Gaudette, D.2
Boynton, J.D.3
Frankel, A.4
Fang, X.-J.5
Sharma, A.6
Hurteau, J.7
Casey, G.8
Goodbody, A.9
Mellors, A.10
Holub, B.11
Mills, G.B.12
-
33
-
-
0024428410
-
Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathway mediated by G proteins
-
Van Corven, E. J., Groenink, A., Jalink, K., Eichholtz, T., and Moolenaar, W. H. Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathway mediated by G proteins. Cell, 59: 45-54, 1989.
-
(1989)
Cell
, vol.59
, pp. 45-54
-
-
Van Corven, E.J.1
Groenink, A.2
Jalink, K.3
Eichholtz, T.4
Moolenaar, W.H.5
-
34
-
-
0026517693
-
Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts
-
Van Corven, E. J., Van Rijswijk, A., Jalink, K., and van Der Bend, R. L., vanBlitterswijk, W. J. and Moolenaar, W. H. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Biochem. J., 281: 163-169, 1992.
-
(1992)
Biochem. J.
, vol.281
, pp. 163-169
-
-
Van Corven, E.J.1
Van Rijswijk, A.2
Jalink, K.3
Van Der Bend, R.L.4
VanBlitterswijk, W.J.5
Moolenaar, W.H.6
-
35
-
-
0025186523
-
Protein kinase C activators sensitize cyclic AMP accumulation by intact 1321N1 human astrocytoma cells
-
Johnson, R. A., and Toews, M. L. Protein kinase C activators sensitize cyclic AMP accumulation by intact 1321N1 human astrocytoma cells. Mol. Pharmacol., 37: 296-303, 1990.
-
(1990)
Mol. Pharmacol.
, vol.37
, pp. 296-303
-
-
Johnson, R.A.1
Toews, M.L.2
-
36
-
-
0022380674
-
Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second messenger role of lysophosphatidic acid
-
Watson, S. P., McConnell, R. T., and Lapetina, E. G. Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second messenger role of lysophosphatidic acid. Biochem. J., 232: 61-66, 1985.
-
(1985)
Biochem. J.
, vol.232
, pp. 61-66
-
-
Watson, S.P.1
McConnell, R.T.2
Lapetina, E.G.3
-
37
-
-
0024495699
-
Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin
-
Gerrard, J. M., and Robinson, P. Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim. Biophys. Acta, 101: 282-285, 1989.
-
(1989)
Biochim. Biophys. Acta
, vol.101
, pp. 282-285
-
-
Gerrard, J.M.1
Robinson, P.2
-
38
-
-
0027232391
-
The bioactive phospholipid lysophosphatidic acid is released from activated platelets
-
Eichholtz, T., Jalink, K., Frhrefort, M., and Moolenaar, W. H. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J , 291: 677-680, 1993
-
(1993)
Biochem. J
, vol.291
, pp. 677-680
-
-
Eichholtz, T.1
Jalink, K.2
Frhrefort, M.3
Moolenaar, W.H.4
-
39
-
-
0028199882
-
LPA: A novel lipid mediator with diverse biological actions
-
Moolenaar, W H. LPA: a novel lipid mediator with diverse biological actions. Trends Cell Biol., 4: 213-218, 1994.
-
(1994)
Trends Cell Biol.
, vol.4
, pp. 213-218
-
-
Moolenaar, W.H.1
-
40
-
-
0027363845
-
Lysophosphatidic acid mimics serum-induced sensitization of cyclic AMP accumulation
-
Kreps, D. M., Whittle, S. M., Hoffman, J. M., and Toews. M. L. Lysophosphatidic acid mimics serum-induced sensitization of cyclic AMP accumulation. FASEB J., 7: 1376-1380, 1993.
-
(1993)
FASEB J.
, vol.7
, pp. 1376-1380
-
-
Kreps, D.M.1
Whittle, S.M.2
Hoffman, J.M.3
Toews, M.L.4
-
41
-
-
0022389184
-
Phosphatidate and monooleylphosphatidate inhibition of fibroblast adenylate cyclase is mediated by the inhibitory coupling protein Ni
-
Proll, M. A., Clark, R. B., and Butcher, R. W. Phosphatidate and monooleylphosphatidate inhibition of fibroblast adenylate cyclase is mediated by the inhibitory coupling protein Ni. Mol. Pharmacol., 28: 331-337, 1985.
-
(1985)
Mol. Pharmacol.
, vol.28
, pp. 331-337
-
-
Proll, M.A.1
Clark, R.B.2
Butcher, R.W.3
-
42
-
-
0027235844
-
Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D
-
Inamura, F., Horai, T., Mukai, M., Shinkai, K, Sawada, M., and Akedo, H. Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D. Biochem. Biophys. Res. Commun., 193: 497-503, 1993.
-
(1993)
Biochem. Biophys. Res. Commun.
, vol.193
, pp. 497-503
-
-
Inamura, F.1
Horai, T.2
Mukai, M.3
Shinkai, K.4
Sawada, M.5
Akedo, H.6
-
43
-
-
0026023499
-
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer
-
Berchuck, A., Rodriguez, G. C., Kamel, A., Dodge, R., Soper, J. T., Clarke-Pearson, D. L , and Bast, R. C. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. Am. J. Obstet. Gynecol., 164, 669-674, 1991.
-
(1991)
Am. J. Obstet. Gynecol.
, vol.164
, pp. 669-674
-
-
Berchuck, A.1
Rodriguez, G.C.2
Kamel, A.3
Dodge, R.4
Soper, J.T.5
Clarke-Pearson, D.L.6
Bast, R.C.7
-
44
-
-
0026005833
-
Evidence for the involvement of transforming growth factor α and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro
-
Morishige, K., Kurachi, H., Amemiya, K., Fujita, Y., Yamamoto, T., Miyake, A., and Tanizawa, O. Evidence for the involvement of transforming growth factor α and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro. Cancer Res., 51: 5322-5328, 1991.
-
(1991)
Cancer Res.
, vol.51
, pp. 5322-5328
-
-
Morishige, K.1
Kurachi, H.2
Amemiya, K.3
Fujita, Y.4
Yamamoto, T.5
Miyake, A.6
Tanizawa, O.7
-
45
-
-
0026336491
-
Importance of transforming growth factor α/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vivo
-
Kurachi, H., Morishige, K., Amemiya, K., Adachi, H., Hirota, K., Miyake, A., and Tanizawa, O. Importance of transforming growth factor α/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vivo. Cancer Res., 51: 5956-5959, 1991.
-
(1991)
Cancer Res.
, vol.51
, pp. 5956-5959
-
-
Kurachi, H.1
Morishige, K.2
Amemiya, K.3
Adachi, H.4
Hirota, K.5
Miyake, A.6
Tanizawa, O.7
-
46
-
-
0021933379
-
Comparative properties of five human ovarian adenocarcinoma cell lines
-
Buick, R. N., Pullano, R., and Trent, J. M. Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res., 45 3668-3676, 1985.
-
(1985)
Cancer Res.
, vol.45
, pp. 3668-3676
-
-
Buick, R.N.1
Pullano, R.2
Trent, J.M.3
-
47
-
-
0021061819
-
Rapid colorimetric assay for cellular growth and survival
-
Mosmann, T. Rapid colorimetric assay for cellular growth and survival. J. Immunol. Methods, 65: 55-63, 1983.
-
(1983)
J. Immunol. Methods
, vol.65
, pp. 55-63
-
-
Mosmann, T.1
-
48
-
-
0018344156
-
Assay for nanogram quantities of DNA in cellular homogenates
-
Brunk, C. F., Jones, K., and James, T. W Assay for nanogram quantities of DNA in cellular homogenates. Anal. Biochem., 92: 497-500, 1979.
-
(1979)
Anal. Biochem.
, vol.92
, pp. 497-500
-
-
Brunk, C.F.1
Jones, K.2
James, T.W.3
-
49
-
-
0017689148
-
Intracellular and in vitro fluorescence of the DNA specific probe: 4′6-diamidino-2-phenylindole (DAPI)
-
Brunk, C. F., and James, T. W. Intracellular and in vitro fluorescence of the DNA specific probe: 4′6-diamidino-2-phenylindole (DAPI). J. Cell Biol., 75: 136a, 1977.
-
(1977)
J. Cell Biol.
, vol.75
-
-
Brunk, C.F.1
James, T.W.2
-
50
-
-
0022553303
-
γ-glutamyltranspeptidase and the Ras-induced transformation of a rat liver cell line
-
Sinha, S., Marshall, C., and Neal, G. γ-glutamyltranspeptidase and the Ras-induced transformation of a rat liver cell line. Cancer Res., 46: 1440-1445, 1986.
-
(1986)
Cancer Res.
, vol.46
, pp. 1440-1445
-
-
Sinha, S.1
Marshall, C.2
Neal, G.3
-
51
-
-
0000943342
-
Agar suspension cultures for the selective assay of cells transformed by polyoma virus
-
Macpherson, I., and Montagnier, L. Agar suspension cultures for the selective assay of cells transformed by polyoma virus. Virology, 23: 291-294, 1964.
-
(1964)
Virology
, vol.23
, pp. 291-294
-
-
Macpherson, I.1
Montagnier, L.2
-
52
-
-
0027453525
-
Tyrosine kinases(s) regulate apoptosis and bcl-2 expression in a growth factor-dependent cell line
-
Otani, H., Erdos, M., and Leonard, J Tyrosine kinases(s) regulate apoptosis and bcl-2 expression in a growth factor-dependent cell line. J. Biol. Chem., 268: 22733-22736, 1993.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 22733-22736
-
-
Otani, H.1
Erdos, M.2
Leonard, J.3
-
53
-
-
0028558727
-
Effects of cytostatic agents on the expression of epidermal growth factor receptor in ovarian cancer cells
-
Lang, T., Daxenbichler, D., and Marth, C. Effects of cytostatic agents on the expression of epidermal growth factor receptor in ovarian cancer cells. Anticancer Res., 14: 1871-1874, 1994.
-
(1994)
Anticancer Res.
, vol.14
, pp. 1871-1874
-
-
Lang, T.1
Daxenbichler, D.2
Marth, C.3
-
54
-
-
0028908979
-
Lysophosphatidic acid induction of transforming growth factors α and β: Modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin
-
Piazza, G., Ritter, J., and Baracka, C. Lysophosphatidic acid induction of transforming growth factors α and β: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin. Exp. Cell Res., 216: 51-64, 1995.
-
(1995)
Exp. Cell Res.
, vol.216
, pp. 51-64
-
-
Piazza, G.1
Ritter, J.2
Baracka, C.3
-
55
-
-
0030044360
-
Role of transactivation of the EGF receptor in signalling G-protein coupled receptors
-
Daub, H., Weiss, F. U., Wallasch, C , and Ullrich, A. Role of transactivation of the EGF receptor in signalling G-protein coupled receptors. Nature (Lond.), 379: 557-560, 1996.
-
(1996)
Nature (Lond.)
, vol.379
, pp. 557-560
-
-
Daub, H.1
Weiss, F.U.2
Wallasch, C.3
Ullrich, A.4
-
56
-
-
0027428571
-
Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatin on well established A431 cell xenografts
-
Fan, Z., Baselga, J., Masui, H., and Mendelsohn, J. Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatin on well established A431 cell xenografts. Cancer Res., 53: 4637-4642, 1993.
-
(1993)
Cancer Res.
, vol.53
, pp. 4637-4642
-
-
Fan, Z.1
Baselga, J.2
Masui, H.3
Mendelsohn, J.4
-
57
-
-
0028115802
-
Bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumors and in situ cancer
-
Leek, R., Kaklamanis, L., Pezzella, F., Gatter, K., and Harris, A. Bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumors and in situ cancer. Br. J. Cancer, 69: 135-139, 1994.
-
(1994)
Br. J. Cancer
, vol.69
, pp. 135-139
-
-
Leek, R.1
Kaklamanis, L.2
Pezzella, F.3
Gatter, K.4
Harris, A.5
-
58
-
-
0025353691
-
Cellular pharmacology of cis-DDP: Perspectives on mechanisms of acquired resistance
-
Andrews, P. A., and Howell, S. B. Cellular pharmacology of cis-DDP: perspectives on mechanisms of acquired resistance. Cancer Cells. 2: 35-43, 1990.
-
(1990)
Cancer Cells
, vol.2
, pp. 35-43
-
-
Andrews, P.A.1
Howell, S.B.2
-
59
-
-
0025052403
-
Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cis-DDP
-
Christen, R. D., Hom, D K., Porter, D. C , Andrews, P. A., Macleod, C. L., Hafstrom, L., and Howell, S. B. Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cis-DDP. J. Clin Invest , 86: 1632-1640. 1990.
-
(1990)
J. Clin Invest
, vol.86
, pp. 1632-1640
-
-
Christen, R.D.1
Hom, D.K.2
Porter, D.C.3
Andrews, P.A.4
Macleod, C.L.5
Hafstrom, L.6
Howell, S.B.7
|